Stock listing
AX9 Stock Price, News, Filings & Events — Akebia Therapeutics, Inc.
Selected listing: AX9 · MUN · EUR · DE
This page tracks Akebia Therapeutics, Inc.'s AX9:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AX9:MUN. AX9:MUN is the stock-level entry point for investors researching Akebia Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Akebia Therapeutics, Inc. (Ticker: AKBA) is a public company based in the United States, with a market capitalization of approximately $327.3 million. The company focuses on developing and commercializing innovative therapies for patients with kidney disease. Akebia is committed to addressing unmet medical needs in this area through its research and development efforts.
- Ticker
- AX9:MUN
- Asset type
- Stock
- Market cap
- $243.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- MUN
- Currency
- EUR
Akebia Therapeutics, Inc. AX9:MUN stock context
This page tracks Akebia Therapeutics, Inc.'s AX9:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AX9:MUN. AX9:MUN is the stock-level entry point for investors researching Akebia Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Akebia Therapeutics, Inc. (Ticker: AKBA) is a public company based in the United States, with a market capitalization of approximately $327.3 million. The company focuses on developing and commercializing innovative therapies for patients with kidney disease. Akebia is committed to addressing unmet medical needs in this area through its research and development efforts.
Latest news from Akebia Therapeutics, Inc.
Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
August 5, 2026
Akebia Therapeutics Announces Initiation of a Phase 2 Basket Trial to Study Ebribafusp, a Next-Generation Complement Inhibitor in Rare Ki...
August 3, 2026
Akebia Therapeutics to Report Second Quarter 2026 Financial Results and Discuss Recent Business Highlights
July 29, 2026
Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio
June 10, 2026
Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
Akebia Therapeutics, Inc. earnings calls
Akebia Therapeutics, Inc. (AKBA) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Akebia Therapeutics, Inc. (AKBA) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Akebia Therapeutics, Inc. (AKBA) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Akebia Therapeutics, Inc. (AKBA) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Akebia Therapeutics, Inc. (AKBA) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for AX9:MUN.
Akebia Therapeutics, Inc. company profile
View the public company page for Akebia Therapeutics, Inc. on 6ix.
Akebia Therapeutics, Inc. news
Read company news and market updates connected to Akebia Therapeutics, Inc..
Akebia Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Akebia Therapeutics, Inc..
Alternate listings
AKBA:NASDAQ
US · USD
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:TRADEGATE
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
A1XF0S:LSX
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AKBA:BOATS
US · USD
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
A1XF0S:LS
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:GETTEX
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:HAM
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:BX
CH · CHF
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:DUS
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:FWB
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.
AX9:SWB
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is AX9:MUN.